retatrutide ly3437943 phase 2 trial obesity nejm 2023 Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide vs Tirzepatide Compared |

Tirzepatide No - standard peptide handling Cagrilintide No - amyloid fibril risk State Light protection Tirzepatide Yes Cagrilintide Yes State Oral viable Tirzepatide No Cagrilintide No Both compounds share similar refrigerator windows

Hold onto all packaging, bottles, and prescription details as evidence

Appetite Control Appetite Control: It helps control your appetite, reduce cravings, and promote healthier eating habits

It induces lipolysis (fat breakdown) in adipose tissue, increasing the production of free fatty acids and ketone bodies

Inside the body, the medications work by mimicking hormones released by the gut after eating, helping regulate blood sugar, slow digestion and keep people feeling full longer